Under NVBDCP, the Mass Drug Administration (MDA) regimen for Lymphatic Filariasis elimination in endemic districts uses which drug combination?

• A Ivermectin alone
• B Diethylcarbamazine (DEC) alone
• C Albendazole plus Ivermectin
• D DEC plus Albendazole ✓

Explanation

The MDA regimen for LF elimination uses a single annual dose of DEC (6 mg/kg) plus albendazole (400 mg). This combination is given to all eligible population (except pregnant women, children under 2 years, and seriously ill persons) in endemic districts to interrupt transmission.

Reference: National Filariasis Control Programme Guidelines, NVBDCP ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.